Annals of
Burns and Fire Disasters - vol. XII - n° 2 - June 1999
GRAM-NEGATIVE
BACTERIAL SURVEILLANCE IN BURN PATIENTS
Arslan E, Dalay C, Yavuz M, Göcenler L, Acartürk S.
Department Of Plastic
And Reconstructive Surgery and Burn Unit, Çukurova University Medical School, Adana,
Turkey
SUMMARY. A retrospective
study of gram-negative bacterial surveillance from the wound swab cultures of burn
patients treated in a major burn unit in Adana, Turkey, was performed. Over a 17-month
period, 232 swab cultures from 114 patients were evaluated and 176 gram-negative
micro-organisms were isolated. Pseudomonas aeruginosa was the organism most
frequently isolated (53.97%). Imipenern-cilastatin was the most active antibiotic to P.
aeruginosa (44%) and to all species (58%). The results showed a very serious
antibiotic resistance of micro-organisms isolated from burn wounds. Surgical excision in
order to remove infected and necrotic tissues from the body is thus confirmed as a routine
basic procedure for the management of burn wounds, and antibiotics should be regarded as
supportive agents.
Introduction
The burn wound represents a susceptible site for opportunistic
colonization by organisms of endogenous and exogenous origin. Patient factors such as age,
extent of injury, and depth of burn in combination with microbial factors such as type and
number of organisms, enzyme and toxin production, and motility determine the likelihood of
invasive burn wound infection. Wound infection cannot be avoided, particularly in large
burn wounds, and this may cause morbidity and mortality. Wound infection may be a source
of sepsis and if it occurs, mortality is never far away. Also, an infected wound sometimes
complicates the procedures of defect closure, such as grafting. This increases the length
of hospital stay and treatment expenses. The most important process is surgical
debridement for removing infected and necrotic tissues from the body. Antibiotic
administration before, during and after surgery is an important part of survival and
appropriate antibiotic treatment is vital. Both facultative and aerobic gramnegative
bacilli and aerobic gram-positive cocci can be isolated in burn wound cultures. Nearly all
these microorganisms are hospital-acquired agents that are resistant to antibiotics to
varying degrees.
In this study, we aimed to study the dissociation and antibiotic susceptibilities of
gram-negative microorganisms isolated in the burn wounds of patients treated in our burn
unit.
Material and methods
Between January 1997 and May 1998, all the burn wound swab cultures
prepared from the patients in our Burn Unit were taken into consideration. In this period
232 different swab samples from 114 patients (72 male, 42 female; m/f ratio = 1.71/1) were
cultured for bacteria. The patients were aged between 6 months and 72 yr (mean, 24.14 ±
12.42). The aetiologies of the burn trauma were scalding (68/114 = 59.64%), flame (27/114
= 23.68%), electricity (11/114 = 9.64%), chemical agents (5/114 = 4.38%), and others
(3/114 = 2.63%). When samples were collected, special attention was paid to areas where
infection was most evident, before dressing changes. The oral, genital, scalp, and anal
regions were never used for sample collection. The areas most preferred were the upper and
lower extremities. Each specimen was identified by a unique accession number, patient
name, and date of specimen collection. All micro-organisms isolated from each specimen
were speciated using conventional methods in the microbiology laboratory. The
micro-organisms were assessed for their susceptibility to 12 antimicrobial agents with
Microscan MSD microtitre plate panel. Endpoints were determined visually or with automated
equipment.
Results
One hundred and seventy-six gram-negative microorganisms were
isolated in 232 swab samples from 114 patients. The distribution of the 176 isolates is
listed in Table I. Almost 74% of the isolates represented species that produce
inducible Richmond-Sykes type 1 cephalosporinase (Table II). Pseudomonas aeruginosa was
the gram-negative micro-organism most frequently isolated, with 95 isolates (53.97%). Proteus
mirabilis was the second commonest, with 18 isolates (10.22%), and Providencia
stuartii third, with 16 isolates (10.22%). P. aeruginosa was isolated alone in
76 samples, with one other bacterial species in 16 samples, two others in two samples, and
three others in one sample.
Organism |
Number |
Percentage |
Pseudomonas aeruginosa |
95 |
53 |
Proteus mirabilis |
18 |
10 |
Providencia stuartii |
16 |
9 |
Providencia rettgeri |
1 |
1 |
Acinetobacter baumanii |
13 |
7 |
Acinetobacter Iwöffi |
11 |
6 |
Klebsiella pneumoniae |
12 |
7 |
E. coli |
5 |
3 |
Pseudomonas vesicularis |
4 |
2 |
Citrobacter freundii |
1 |
1 |
|
Enterobacter sp. |
Serratia sp. |
Providencia sp. |
Citrobacter freundii |
Morganella morgani |
Pseudomonas aeruginosa |
Indol-positive Proteus sp. |
|
Table 1 -
Prevalence of gram-negative bacilli isolated from swab cultures of burn wounds |
Table Il -
Gram-negative bacilli that can produce type-1 cephalosporinase by induction (adapted from
Sanders et al. and Dworzack et al.) |
|
When antibiotic
susceptibility for P. aeruginosa was evaluated, in 18 samples all 12 antibiotics
showed resistance to P. aeruginosa (19%); these were defined as pan-resistant P. aeruginosa.
In 24 samples, only one antibiotic was susceptible to P. aeruginosa (25%);
these were defined as multi-resistant P. aeruginosa. In 53 other samples, at least
two antibiotics were susceptible to P. aeruginosa (55%). In multi-resistant
samples, imipenemcilastatin was susceptible in 17 samples (70.83%), ceftazidime in four
samples (16.66%), and cyprofloxacin, amikasin, and ticarcillin/clavulanate in one sample
(4.16%). When P. aeruginosa samples were considered in general, imipenem-cilastatin
was the antibiotic most susceptible to P. aeruginosa, with a ratio of 42/95 (44.21
%). Ceftazidime was the second most susceptible, with a ratio of 29/95 (30.52%), and
cyprofloxacin third, with a ratio of 28/95 (29.47%).
Proteus mirabilis, with a 10.22% ratio, was the second most frequently isolated
micro-organism in burn wounds. Cyprofloxacin was found to be the most susceptible
antibiotic to this micro-organism, with a ratio of 94.44%. Imipenem-cilastatin and
ticarcillin-clavulanate were second in line with the same ratio of 77.77%. The third most
frequently isolated micro-organism was Providencia stuartfl with 9.09%.
Cyprotloxacin and ticarcillinclavulanate were the most susceptible antibiotics, with 75%.
imipenem-cilastatin followed, with 68.75%.
Citrobacter freundii was isolated in one sample and imipenem-cilastatin was the
only susceptible antibiotic.
Providencia rettgeri was isolated in one sample and was resistant to
imipenem-cilastatin.
Overall, imipenem-cilastatin (58%), cyprofloxacin (52%), and ticarcillin/clavulanate (35%)
demonstrated the best activity against the gram-negative bacterial isolates. Many bacteria
that were resistant to ceftazidime demonstrated cross-resistance to other third-generation
cephalosporins. The micro-organisms isolated and antibiotic susceptibilities are shown in Table
III.
Species (N') |
Imipenem |
Ceftazidime |
Cyprofloxacin |
Ticarcillin
/Clavulanate |
Amikasin |
Gentamicin |
P. aeruginosa (95) |
44% |
30% |
29% |
22% |
16% |
7% |
Proteus mirabilis (18) |
77% |
- |
- |
94% |
77% |
33% |
Providencia stuartii (16) |
68% |
|
75% |
75% |
43% |
|
Acinetobacter baumanii (13) |
92% |
|
77% |
23% |
- |
|
Klebsiella pneumonia (12) |
75% |
16% |
100% |
16% |
75% |
33% |
Acinetobacter Iwbffi (11) |
54% |
9% |
45% |
27% |
18% |
18% |
E. coli (5) |
60% |
|
60% |
40% |
60% |
20% |
P. vesicularis (4) |
100% |
|
75% |
75% |
|
|
Providencia rettgeri (1) |
- |
|
100% |
100% |
|
|
Citrobacter freundi (1) |
100% |
|
- |
- |
|
|
All species |
58% |
18% |
52% |
35% |
24% |
7% |
Species (N') |
Tobramyein |
Aztreonarn |
Ceftriaxon |
Cefoperazon |
Cefotaxime |
Piperacillin |
P. aeruginosa (95) |
14% |
12% |
1% |
12% |
3% |
17% |
Proteus mirabilis (18) |
|
61% |
22% |
|
11% |
22% |
Providencia stuarti (16) |
- |
6% |
6% |
|
6% |
6% |
Acinetobacter baumanii (13) |
30% |
- |
- |
- |
- |
|
Klebsiella pneumonia (12) |
16% |
41% |
41% |
16% |
25% |
- |
Acinetobacter Iw,)ffi (11) |
36% |
18% |
18% |
- |
18% |
9% |
E. coli (5) |
20% |
20% |
20% |
|
60% |
20% |
P. vesicularis (4) |
25% |
|
|
|
25% |
|
Providencia rettgeri (1) |
|
|
100% |
|
|
|
Citrobacterfreundii (1) |
|
|
|
|
|
|
All species |
14% |
18% |
9% |
7% |
9% |
13% |
Table III -
Susceptibilities (percentage) of gram-negative micro-organisms isolated from burn patients
with wound infection to 12 antibiotics |
Discussion
Our study mainly depends on surface
swab cultures. Quantitative microbiology has recently become popular and many reports deal
with it. Comparing the two methods, it can be said that the use of quantitative
microbiology in burns is limited by the unreliability of a single surface swab or biopsy
for the representation of the whole burn wound, and it is suggested that quantitative
bacteriology by burn wound biopsy or surface swab does not aid the in prediction of sepsis
or graft loss The surface swab culture method cannot be ignored and still has its
importance, particularly in routine practice.
From a review of the literature it would seem that our study is one of the widest reports
of the prevalence and antimicrobial susceptibilities of gram-negative bacteria isolated
from infected burn wounds. In the population studied, P. aeruginosa, P. mirabilis and
P. stuartii were the most frequent isolates. Together they accounted for 72% of the
gram-negative organisms collected. Susceptibility studies showed that imipenem-cilastatin,
cyprofloxacin, and ticarcillin-clavulanate exerted the best activity against almost all
the micro-organisms that were susceptible to antibiotics. The gram-negative bacilli that
were resistant to ceftazidime frequently demonstrated crossresistance to other
cephalosporins. However these organisms remained susceptible to imipenem-cilastatin.
Of the microbial population, P. aeruginosa was the most frequently cultured
organism, representing 53% of all the isolates collected. The reasons for this high
prevalence are as follows: factors associated with the acquisition of nosocomial pathogens
in patients with recurrent or longterm hospitalization, complicating illnesses, prior
administration of antimicrobial agents, the immunesuppressive effects of burn trauma, and
other factors as yet unknown.Of great interest to us was the finding that nearly 74% of
the gram-negative isolates were organisms associated with the production of inducible
RichmondSykes type 1 cephalosporinase. These organisms produce large quantities of type 1
cephalosporinase when exposed to first-generation cephalosporins, ampicillin, and
penicillin G. As these antimicrobials are also readily hydrolysed by this enzyme,
inducible organisms are intrinsically resistant to these agents.
Our in vitro data suggest that ceftazidime, a thirdgeneration cephalosporin, is not
active against organisms that produce inducible type I cephalosporinase, except P. aeruginosa.
This may demonstrate some other properties of P. aeruginosa different from this
mechanism.
Sanders and Sanders reported that resistance emerged in 14 to 56% of organisms when
cephalosporins were used to treat infections caused by type I cephalosporinaseinducible
bacteria. Importantly, treatment with a combination of a cephalosporin and an
aminoglycoside did not appear to decrease the emergence of beta-lactarn resistance Studies
have shown that broad-spectrum activity of imipenem-cilastatin monotherapy is as
efficacious as combination antimicrobial regimens in the treatment of serious polymicrobial infections. Moreover, the combination of imipenem-cilastatin with amino
glycoside does not appear to reduce the incidence of resistance acquisition.
Milatovic and Braveny reviewed the literature and found that
as many as 24.5% of P. aeruginosa isolates may become resistant to
imipenem-cilastatin during therapy.
These observations, together with our finding that bacteria associated with inducible type
I cephalosporinase account for nearly 74% of the organisms in our study population,
suggest that empirical use of cephalosporins or penicillins to treat burn wound infections
should be performed with caution.
In our study, imipenem-cilastatin, a carbapenem beta-lactam antimicrobial with
broad-spectrum activity against gram-positive cocci, gram-negative bacilli, and obligate
anaerobes, demonstrated the best activity against gram-negative micro-organisms. However,
in our series P. aeruginosa became resistant to imipenem-cilastatin with a rate of
nearly 56%. This was the highest resistance rate of P. aeruginosa to
imipenem-cilastatin. Also, it was seen that monotherapy with imipenem-cilastatin would not
be suitable for adequate management of P. aeruginosa isolated in burn wounds. A
combination of imipenem-cilastatin with an aminoglycoside appeared to be needed.
A basic procedure such as surgical excision must be correctly performed and antimicrobial
agents should then be applied. Surgical excision is the recommended procedure for the
management of infected burn wounds, as proposed by Pruitt.
Conclusions
Our study shows, once
again, that antibiotics alone can never be sufficient in the management of infected burn
wounds. In addition, it can easily be seen that as time goes on we may expect that
antibiotics will come to mean less than they do today. As a supportive agent they are
today still significant. On the basis of this consideration, a combination of
imipenem-cilastatin with an aminoglycoside should be administered together in order to
widen the spectrum, particularly in the case of P. aeruginosa.
RESUME. Les
Auteurs ont effectué une étude rétrospective de la surveillance bactérienne à Gram
négatif des cultures des tampons des lésions des patients traités dans une importante
unité des brûlures à Adana, Turquie. Pendant une période de 17 mois, ils ont évalué
232 cultures de tampons provenant de 114 patients et 176 micro-organismes
à Gram négatif ont été isolés. L'organisme isolé le plus fréquemment était
Pseudomonas - aeruginosa (53,9711/o). L'imipenem-cilastatin s'est démontré
l'antibiotique le plus actif contre P. aeruginosa (44%) et à toutes les espèces (58%).
Les résultats indiquaient une importante résistance antibiotique des micro organismes
isolés dans les lésions. Les Auteurs ont donc confirmé que l'excision chirurgicale pour
l'élimination des tissus infectés et nécrosés du corps reste une procédure de base de
routine dans le traitement des brûlures, et qu'il faut considérer les antibiotiques
comme des agents de support.
BIBLIOGRAPHY
- Pruitt B.A., Jr, McManus Kim S.H., Goodwin C.W.:
Burn wound infections: current status. World J. Surg., 22: 135, 1998.
- McCarthy J., May JW., Littler JR.: "Plastic Surgery", vol. 1,
Saunders, Philadelphia, 1990.
- Demling R.H., La Londe C. : "Burn
Trauma", vol. 4, New York, 1989.
- Mooney D.P., Gamelli R.L., O'Reilly M. et al.:
Recombinant human granulocyte colony- stimulating factor and Pseudomonas burn wound
sepsis. Archives of Surgery, 123: 1353, 1988.
- Silver G.M., Gamelli R..L, O'Reilly M. et al.: The
beneficial effect of granulocyte colony-stimulating factor (G-CSF) in combination with
gentamicin on survival after Pseudomonas burn wound infection. Surgery, 106: 452, 1989.
- Louie A., Balteh A., Smith R.P.: Gram-negative
bacteria surveillance in diabetic patients. Infec. Med., 10: 33, 1993.
- O'Reilly M., Silver G.M., Gamelli R.L. et al.:
Dose dependency of granulocyte-macrophage colony-stimulating fActor for improving survival
following burn wound infection. J. Trauma, 36: 486, 1994.
- Morrison A.J., Jr, Wenzel R.P.: Epidemiology of
infections due to Pseudomonas aeruginosa. Rev. Infect. Dis., 6: 627, 1984.
- Cross A., Alien J.R., Burke J. et al.: Nosocomial
infections due to Pseudomonas aeruginosa: Review of recent trends. Rev. Infect. Dis., 5:
837, 1983.
- Livermore D.M.: Mechanisms of resistance to
beta-lactam antibiotics. Scand. J. Infect. Dis., 78: 7, 1991.
- Sanders W.E., Jr, Sanders C.C.: Inducible
beta-lactamases: Clinical and epidemiological implications for use newer cephalosporms.
Rev. Infect. Dis., 10: 830, 1988.
- Chow J.W., Fine M.J., Shlaes D.M. et al.:
Enterobacter bacteremia: Clinical features and emergence of antibiotic resistance during
therapy. Ann. Intern. Med., 115: 585, 1991.
- Dworzack D.L., Pugsley M.P., Sanders C.C. et al.:
Emergence of resistance in gram-negative bacteria during therapy with extended-spectrum
cephalosporins. Ent. J. Clin. Microbiol., 6: 456, 1987.
- Chandrasekar P.H., Crane L.R., Bailey E.J.:
Comparison of the activity of antibiotic combinations in vitro with outcome and resistance
emergence in serious infections by Pseudontonas aeruginosa in non-neutropenic patients.
Antimicrob. Agents Chemother., 19: 321, 1987.
- Lipman B., Neu H.C.: Imipenem: A new carbapenem
antibiotic. Med. Clin. North Am., 72: 567, 1988.
- Jones RX: Review of the in vitro spectrum of
activity of imipenem. Am. J. Med., 78: 22, 1985.
- Neu H.C.: Resistance of Pseudomonas aeruginosa to
imipenem. Infect. Control Hosp. Epidemiol., 13: 7, 1992.
- Rice L.B., Eliopulos G.M.: Imipenem and aztreonam:
Current role in antimicrobial therapy. Curt. Clin. Top. Infect. Dis., 10: 109, 1989.
- Mialtovic D., Braveny I.: Development of
resistance during antibiotic therapy. Ent. J. Clin. Microbiol., 6: 234, 1987.
- Steer J.A., Papini R., Wilson A.P. et al.:
Quantitative microbiology in the management of burn patients. 1. Correlation between
quantitative and qualitative burn wound biopsy culture and surface alginate swab culture.
Burns, 22: 173, 1996.
Steer J.A., Papini R.P.,
Wilson A.P. et al.: Quantitative microbiology in the management of burn patients. 11.
Relationship between bacterial counts obtained by burn wound biopsy culture and surface
alginate swab culture, with clinical outcome following burn surgery and change of
dressing. Burns, 22: 3, 177, 1996.
This paper was received on 9 November
1998.
Address correspondence to: Dr Emrah Arslar
Cukurova Universitesi Tip Fakultesi, Plastik Ve Rekonstruktif Cerrahi A.D.
01130, Adana, Turkey
(fax: 90 322 338 6427). |
|